{
  "schema": "vedokrok.public-item.v1",
  "release_id": "VEDOKROK-SEL-5d86e1b23401e578",
  "url": "/knowledge/a-changed-biomarker-is-not-automatically-a-changed-life",
  "id": "MHC-D-RESEARCH-0066",
  "version": "0.1.0",
  "title": "A changed biomarker is not automatically a changed life",
  "summary": "The dashboard can move before the destination is established.",
  "kind": "concept",
  "body": "A surrogate stands in for an outcome of interest. Ask what evidence validates that substitution in this context; an attractive mechanism alone does not finish the argument.",
  "limits": [
    "Some surrogate endpoints are well validated and useful. Do not reject all biomarkers or change care because a direct long-term endpoint was not measured."
  ],
  "topics": [
    "critical-thinking"
  ],
  "intents": [],
  "source_ids": [
    "fda-surrogate-endpoints"
  ],
  "evidence": [
    {
      "claim": "A surrogate endpoint substitutes for a clinical outcome and requires context-specific evidence of its predictive value.",
      "source_id": "fda-surrogate-endpoints",
      "role": "supports",
      "note": "Claim basis: technical_definition. Claim limit: Some surrogates are well validated; others remain candidates.\nSource access: selected_html_passages; accessed on: 2026-09-17; inspected sections: [\"What are clinical trial endpoints?\", \"How can biomarkers be used as surrogate endpoints?\"].\nAgent scope review: FDA defines a surrogate as a substitute for a direct measure of how a patient feels, functions or survives and explains that its validation depends on context. The card gives a fictional example and explicitly rules out changing care on this basis.",
      "locator": "Clinical trial endpoints; biomarkers as surrogate endpoints"
    }
  ],
  "use_when": [
    "A product's benefit is inferred from a laboratory measure rather than how people feel, function or survive."
  ],
  "avoid_when": [
    "Some surrogate endpoints are well validated and useful. Do not reject all biomarkers or change care because a direct long-term endpoint was not measured."
  ],
  "example": "A fictional intervention changes a measured molecule. Without suitable validation or outcome evidence, that is not yet proof that users feel better or live longer.",
  "check": "Can you distinguish what was measured from the benefit being promised?",
  "published_at": "2026-11-12T17:42:00Z",
  "review": {
    "kind": "agent",
    "label": "Agent editorial and scoped source review",
    "reviewed_at": "2026-11-12T17:42:00Z"
  },
  "knowledge_origin": {
    "release_id": "MHC-RPUB-20261112-07d31a69",
    "corpus_commit": "07d31a6904d38f9fe2189aee7b26bb065724b120",
    "manifest_sha256": "d676e87a17b9210d8037fd74c3f1ea735debd384fa069ba127a87ad441aa4f20",
    "projection_sha256": "7e7900a14145b4d025c2279ceb005ff3633adb88263038886b09282e4dafb04b",
    "published_at": "2026-11-12T17:42:00Z"
  },
  "editorial_overlay": null,
  "editorial": null,
  "notices": [],
  "sources": [
    {
      "id": "fda-surrogate-endpoints",
      "title": "Surrogate Endpoint Resources for Drug and Biologic Development",
      "url": "https://www.fda.gov/drugs/development-resources/surrogate-endpoint-resources-drug-and-biologic-development"
    }
  ],
  "relations": [
    {
      "from": "MHC-D-RESEARCH-0066",
      "to": "MHC-D-RESEARCH-0071",
      "type": "useful_with",
      "url": "/knowledge/keep-evidence-certainty-attached-to-its-outcome"
    }
  ],
  "collections": [
    {
      "id": "RC-RESEARCH-READ-STUDY-BEHIND-PROMISE",
      "title": "Read the study behind the promise",
      "url": "/collections/read-the-study-behind-the-promise"
    }
  ],
  "topic_hubs": [
    {
      "id": "critical-thinking",
      "title": "Critical thinking and evidence",
      "url": "/topics/critical-thinking"
    }
  ],
  "solution_packs": []
}
